Ischemic Stroke Surgery Market Research, Revenue Growth, Size, Regional Share Analysis & Forecast Till 2035

Comments · 45 Views

The ischemic stroke surgery market is anticipated to reach USD 7.26 billion by 2035 and post a CAGR of 8.70% from 2022 to 2035.

An ischemic stroke is characterized by a rapid loss of certain brain functions by an unequal or insufficient blood supply to the brain. The main causes of acute ischemic dysfunction include atherosclerosis plaques that obstruct blood vessels, blood clots that block blood circulation to or from the arteries supporting the brain, or brain artery constriction. The ischemic stroke surgery market is anticipated to reach USD 7.26 billion by 2035 and post a CAGR of 8.70% from 2022 to 2035.

The adoption and introduction of technologically sophisticated products, the rise in preference for minimally invasive procedures, and an increase in physical inactivity and unhealthy lifestyles are some of the reasons driving the global market for ischemic stroke surgery. Additionally, it is anticipated that RD expenditures and activities will generate profitable growth prospects for market participants throughout the projected period. Over the projected period, the market expansion will be constrained by the absence of medical facilities across developing nations and a skilled labor shortage. One of the key factors anticipated to drive the growth and demand of the ischemic stroke surgery market is the quick technological advancement in diagnostic and surgical equipment.

Segmental Analysis

By product type, the ischemic stroke surgery market research includes catheters, aspiration systems, guidewires, microcatheter, and others. By end user, the ischemic stroke surgery market includes hospitals, clinics, ambulatory surgical centers, and others. By type of surgery, the ischemic stroke surgery market includes thrombectomy, revascularization surgery, carotid endarterectomy, and angioplasty.

Detailed Regional Analysis

Acute ischemic stroke patients are becoming more prevalent, and cutting-edge technical diagnostics like neurological computed tomography scans and magnetic resonance imaging examinations fuel the expansion of the North American market (MRI). A major growth factor in North America is the high prevalence of acute and chronic ischemic strokes. Additionally, as older adults over 75 are more likely to experience ischemic strokes, the region's growing geriatric population is one of the main factors. Significant risk variables for ischemic stroke have been found to include unhealthy diets, smoking, physical inactivity, poor food, and obesity in European nations.

Although non-communicable diseases are widespread, sub-Saharan Africa has the highest prevalence of the illnesses. In sub-Saharan Africa, non-communicable diseases are the second leading cause of death (SSA). Cardiovascular illnesses are the leading cause of NCD fatalities. As a result, ischemic stroke operations are in high demand, fueling the market's growth.

Competitive Analysis

It is anticipated that the emphasis on sustainability-related objectives will accelerate the next stage of development in the worldwide market. It is predicted that increased business spending on RD will accelerate the market's growth. It is anticipated that development opportunities will arise from the effective and advanced use of raw materials over the projection period. The market is expected to see a choppy growth phase as the return to normalcy could happen gradually. Lockdown measures are sporadically lifted or imposed in several countries, which could slow market growth. According to estimates, the top market players will pursue strategies to strengthen and improve their global positions through acquisitions and new product introductions.

The formidable players in the ischemic stroke surgery market are Penumbra, Inc. (US), Stryker (US), Medtronic PLC (Ireland), Abbott Laboratories (US), Koninklijke Philips N.V. (Netherlands), Abbott Laboratories (US), Johnson Johnson Services Inc. (US), Imperative Care (US), Boston Scientific Corporation (US), and Phenox GmbH (Germany).

Access full report @

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071